This is the authors' abstract. We don't add key points for this paper.
Objectives: To quantify changes in the volume, methods, and clinical maturity of artificial intelligence (AI) and machine learning (ML) research in major medical journals from 2018 through 2025.Methods: We conducted a longitudinal bibliometric study of PubMed-indexed records from 99 leading clinical and general medical journals. The search was conducted on July 2026. Records were deduplicated and classified as empirical AI/ML research, evidence synthesis, AI discourse, or unclassified. Empirical studies were categorized by model family and clinical maturity. Journal-year Poisson generalized estimating equations used total substantive publications as an offset and clustered observations by journal.Results: Among 6,891 unique publications, 4,205 (61%) were empirical AI/ML studies. Empirical articles increased from 213 in 2018 to 903 in 2025. The adjusted publication rate rose by 20.5% annually (incidence rate ratio, 1.205; 95% confidence interval, 1.166–1.245; p < 0.001). Blinded validation yielded 92.7% agreement (Cohen's kappa, 0.854). Traditional ML remained dominant, while transformer, large language model, and generative AI studies rose sharply after 2022. Overall, 81.9% of empirical studies were retrospective development studies, and 17.4% reached external validation, prospective evaluation, or real-world deployment.Conclusion: The AI/ML research became a larger component of major-journal output, but clinical translation lagged behind publication growth. Progress should be assessed through external validation, prospective evaluation, real-world effectiveness, equity, and transparent reporting.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Alsaeedi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: